Marie‐Pierre Sunyach

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

M. Savina, Axel Le Cesne, Jean‐Yves Blay et al. · BMC Medicine · 2017 · 206 citations · Full text

Common Strategy for Adult and Pediatric Medulloblastoma: A Multicenter Series of 253 Adults

Laëtitia Padovani, Marie‐Pierre Sunyach, David Pérol et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 157 citations

Neuro-oncology, Pediatric Brain Tumors, Pediatric Neurosurgery +7

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)

Ronald B. Keus, Remi A. Nout, Jean‐Yves Blay et al. · Annals of Oncology · 2013 · 134 citations · Full text

Radiation Medicine, Eortc 62991–22998, Radiation Therapy +11

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity

Adeline Granzotto, Mohamed Amine Benadjaoud, Guillaume Vogin et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 119 citations

Atm Protein, Radiation Therapy, Radiobiology +12